Published in AIDS Weekly, January 28th, 2002
SMART, or Strategies for Management of Anti-Retroviral Therapies, will eventually enroll 6000 people who will be monitored for up to 9 years. The study is being conducted by the Community Programs for Clinical Research on AIDS (CPCRA), a network of community-based researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID).
People with HIV and their doctors can take one of two approaches when tackling the disease. They may either suppress the virus...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.